Published in J Alzheimers Dis on January 01, 2009
Identification of brain-targeted bioactive dietary quercetin-3-O-glucuronide as a novel intervention for Alzheimer's disease. FASEB J (2012) 1.01
Caregiver burden and psychoeducational interventions in Alzheimer's disease: a review. Dement Geriatr Cogn Dis Extra (2012) 1.01
Caregiver Burden in Alzheimer's Disease: Differential Associations in Adult-Child and Spousal Caregivers in the GERAS Observational Study. Dement Geriatr Cogn Dis Extra (2014) 0.86
Psychotropic medication burden and factors associated with antipsychotic use: an analysis of a population-based sample of community-dwelling older persons with dementia. J Am Geriatr Soc (2011) 0.84
Cognition in patients with newly diagnosed brain metastasis: profiles and implications. J Neurooncol (2014) 0.83
Grouping of behavioural and psychological symptoms of dementia. Int J Geriatr Psychiatry (2013) 0.80
Factors Associated with Caregiver Burden in Dementia: 1-Year Follow-Up Study. Psychiatry Investig (2015) 0.78
Impact of behavioral subsyndromes on cognitive decline in Alzheimer's disease: data from the ICTUS study. J Neurol (2013) 0.77
Prevalence and risk factors of cognitive impairment in Parkinson disease: a population-based case-control study in Taiwan. Medicine (Baltimore) (2015) 0.75
Phase 3 trials of solanezumab for mild-to-moderate Alzheimer's disease. N Engl J Med (2014) 6.67
Frailty consensus: a call to action. J Am Med Dir Assoc (2013) 6.54
A roadmap for the prevention of dementia: the inaugural Leon Thal Symposium. Alzheimers Dement (2008) 6.39
Sarcopenia: an undiagnosed condition in older adults. Current consensus definition: prevalence, etiology, and consequences. International working group on sarcopenia. J Am Med Dir Assoc (2011) 5.96
Protective variant for hippocampal atrophy identified by whole exome sequencing. Ann Neurol (2015) 5.10
Developing a national strategy to prevent dementia: Leon Thal Symposium 2009. Alzheimers Dement (2010) 4.85
Comparative effectiveness of MRI in breast cancer (COMICE) trial: a randomised controlled trial. Lancet (2010) 4.79
A phase 3 trial of semagacestat for treatment of Alzheimer's disease. N Engl J Med (2013) 4.11
Exercise program for nursing home residents with Alzheimer's disease: a 1-year randomized, controlled trial. J Am Geriatr Soc (2007) 4.05
Association of plasma clusterin concentration with severity, pathology, and progression in Alzheimer disease. Arch Gen Psychiatry (2010) 3.64
18F-flutemetamol amyloid imaging in Alzheimer disease and mild cognitive impairment: a phase 2 trial. Ann Neurol (2010) 3.49
Frequency of malnutrition in older adults: a multinational perspective using the mini nutritional assessment. J Am Geriatr Soc (2010) 3.05
Outcome of Alzheimer's disease: potential impact of cholinesterase inhibitors. J Gerontol A Biol Sci Med Sci (2006) 2.76
Long-term use of standardised Ginkgo biloba extract for the prevention of Alzheimer's disease (GuidAge): a randomised placebo-controlled trial. Lancet Neurol (2012) 2.65
Sarcopenia with limited mobility: an international consensus. J Am Med Dir Assoc (2011) 2.34
Self-referential reflective activity and its relationship with rest: a PET study. Neuroimage (2005) 2.28
Prediction of conversion from mild cognitive impairment to Alzheimer's disease dementia based upon biomarkers and neuropsychological test performance. Neurobiol Aging (2010) 2.27
Distinct regions of the medial prefrontal cortex are associated with self-referential processing and perspective taking. J Cogn Neurosci (2007) 2.02
Designing drug trials for Alzheimer's disease: what we have learned from the release of the phase III antibody trials: a report from the EU/US/CTAD Task Force. Alzheimers Dement (2013) 1.98
Sarcopenia, calf circumference, and physical function of elderly women: a cross-sectional study. J Am Geriatr Soc (2003) 1.93
Orbitofrontal cortex involvement in chronic analgesic-overuse headache evolving from episodic migraine. Brain (2005) 1.90
The assessment of frailty in older adults. Clin Geriatr Med (2010) 1.89
Efficacy of donepezil on maintenance of activities of daily living in patients with moderate to severe Alzheimer's disease and the effect on caregiver burden. J Am Geriatr Soc (2003) 1.83
Diabetes is associated with subclinical functional limitation in nondisabled older individuals: the Health, Aging, and Body Composition study. Diabetes Care (2003) 1.77
Physical performance measures as predictors of mortality in a cohort of community-dwelling older French women. Eur J Epidemiol (2006) 1.76
Efficacy of donepezil on behavioral symptoms in patients with moderate to severe Alzheimer's disease. Int Psychogeriatr (2002) 1.73
Proinflammatory cytokines, aging, and age-related diseases. J Am Med Dir Assoc (2013) 1.69
Difficulties with physical function associated with obesity, sarcopenia, and sarcopenic-obesity in community-dwelling elderly women: the EPIDOS (EPIDemiologie de l'OSteoporose) Study. Am J Clin Nutr (2009) 1.68
Body mass index is associated with biological CSF markers of core brain pathology of Alzheimer's disease. Neurobiol Aging (2011) 1.57
A pan-European study of the C9orf72 repeat associated with FTLD: geographic prevalence, genomic instability, and intermediate repeats. Hum Mutat (2013) 1.53
Endpoints for trials in Alzheimer's disease: a European task force consensus. Lancet Neurol (2008) 1.51
Aggressive course of disease in dementia. Alzheimers Dement (2006) 1.44
Multivariate analysis of MRI data for Alzheimer's disease, mild cognitive impairment and healthy controls. Neuroimage (2010) 1.44
The neural basis of personal goal processing when envisioning future events. J Cogn Neurosci (2010) 1.42
Patient and caregiver perspectives of quality of life in dementia. An investigation of the relationship to behavioural and psychological symptoms in dementia. Dement Geriatr Cogn Disord (2008) 1.41
Minimum data set for nutritional intervention studies in elderly people. J Gerontol A Biol Sci Med Sci (2004) 1.40
Sensory alien hand syndrome in corticobasal degeneration: a cerebral blood flow study. Mov Disord (2010) 1.40
Early prediction of failure to lose weight after obesity surgery. Surg Obes Relat Dis (2011) 1.40
Experience and opinions on post-graduate dementia training in the UK: a survey of selected consultant geriatricians. Age Ageing (2013) 1.39
Normalized Mini-Mental State Examination for assessing cognitive change in population-based brain aging studies. Neuroepidemiology (2014) 1.39
Music perception in adult cochlear implant recipients. Acta Otolaryngol (2003) 1.38
Neuropsychiatric syndromes in dementia. Results from the European Alzheimer Disease Consortium: part I. Dement Geriatr Cogn Disord (2007) 1.38
Biomarkers of sarcopenia in clinical trials-recommendations from the International Working Group on Sarcopenia. J Cachexia Sarcopenia Muscle (2012) 1.37
Exploring the unity and diversity of the neural substrates of executive functioning. Hum Brain Mapp (2005) 1.36
Frailty: toward a clinical definition. J Am Med Dir Assoc (2008) 1.36
The AddNeuroMed framework for multi-centre MRI assessment of Alzheimer's disease: experience from the first 24 months. Int J Geriatr Psychiatry (2011) 1.35
Dementia prevention: methodological explanations for inconsistent results. Epidemiol Rev (2008) 1.35
The frailty phenotype and the frailty index: different instruments for different purposes. Age Ageing (2013) 1.35
Automated hippocampal shape analysis predicts the onset of dementia in mild cognitive impairment. Neuroimage (2011) 1.34
Homeostatic sleep pressure and responses to sustained attention in the suprachiasmatic area. Science (2009) 1.30
AddNeuroMed--the European collaboration for the discovery of novel biomarkers for Alzheimer's disease. Ann N Y Acad Sci (2009) 1.30
Disease-modifying trials in Alzheimer's disease: a European task force consensus. Lancet Neurol (2007) 1.29
'Clinical trials in Alzheimer's disease': immunotherapy approaches. J Neurochem (2011) 1.29
Candidate blood proteome markers of Alzheimer's disease onset and progression: a systematic review and replication study. J Alzheimers Dis (2014) 1.29
Does retirement affect cognitive functioning? J Health Econ (2012) 1.29
MRI measures of Alzheimer's disease and the AddNeuroMed study. Ann N Y Acad Sci (2009) 1.28
Muscle strength in obese elderly women: effect of recreational physical activity in a cross-sectional study. Am J Clin Nutr (2004) 1.26
Biomarkers for Alzheimer's disease therapeutic trials. Prog Neurobiol (2010) 1.26
Diabetes, hyperglycemia, and inflammation in older individuals: the health, aging and body composition study. Diabetes Care (2006) 1.26
Orbitofrontal dysfunction related to both apathy and disinhibition in frontotemporal dementia. Dement Geriatr Cogn Disord (2006) 1.25
Physical activity and Alzheimer's disease: from prevention to therapeutic perspectives. J Am Med Dir Assoc (2008) 1.24
Strontium ranelate reduces the risk of vertebral and nonvertebral fractures in women eighty years of age and older. J Bone Miner Res (2006) 1.24
TLC1 RNA nucleo-cytoplasmic trafficking links telomerase biogenesis to its recruitment to telomeres. EMBO J (2008) 1.24
AddNeuroMed and ADNI: similar patterns of Alzheimer's atrophy and automated MRI classification accuracy in Europe and North America. Neuroimage (2011) 1.24
Dysexecutive syndrome: diagnostic criteria and validation study. Ann Neurol (2010) 1.22
International Association of Gerontology and Geriatrics: a global agenda for clinical research and quality of care in nursing homes. J Am Med Dir Assoc (2011) 1.22
Is there a relationship between fat-free soft tissue mass and low cognitive function? Results from a study of 7,105 women. J Am Geriatr Soc (2002) 1.20
Self-reflection across time: cortical midline structures differentiate between present and past selves. Soc Cogn Affect Neurosci (2008) 1.19
Nutrition and neurodegeneration: epidemiological evidence and challenges for future research. Br J Clin Pharmacol (2013) 1.15
Involvement of both prefrontal and inferior parietal cortex in dual-task performance. Brain Res Cogn Brain Res (2005) 1.14
Effect of APOE ε4 allele on cortical thicknesses and volumes: the AddNeuroMed study. J Alzheimers Dis (2010) 1.12
Valuing one's self: medial prefrontal involvement in epistemic and emotive investments in self-views. Cereb Cortex (2011) 1.12
Evidence of altered phosphatidylcholine metabolism in Alzheimer's disease. Neurobiol Aging (2013) 1.12
Moving towards early clinical trials for amyloid-targeted therapy in Alzheimer's disease. Nat Rev Drug Discov (2013) 1.12
Efficacy of Souvenaid in mild Alzheimer's disease: results from a randomized, controlled trial. J Alzheimers Dis (2012) 1.11
Mitochondrial dysfunction and immune activation are detectable in early Alzheimer's disease blood. J Alzheimers Dis (2012) 1.11
Consistency of neuropsychiatric syndromes across dementias: results from the European Alzheimer Disease Consortium. Part II. Dement Geriatr Cogn Disord (2007) 1.10
Sensitivity and specificity of medial temporal lobe visual ratings and multivariate regional MRI classification in Alzheimer's disease. PLoS One (2011) 1.10
Grouping for behavioral and psychological symptoms in dementia: clinical and biological aspects. Consensus paper of the European Alzheimer disease consortium. Eur Psychiatry (2005) 1.09
Caloric restriction and brain function. Curr Opin Clin Nutr Metab Care (2008) 1.09
Validation of Alzheimer's disease CSF and plasma biological markers: the multicentre reliability study of the pilot European Alzheimer's Disease Neuroimaging Initiative (E-ADNI). Exp Gerontol (2009) 1.09